61 /100
HIGH RISK
Score updated Jul 14, 2026

OBIO — Orchestra BioMed Holdings, Inc. Dilution Risk Tracker

Track OBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OBIO — Get alerts when the score changes →

As of July 14, 2026, Orchestra BioMed Holdings, Inc. (OBIO) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. Orchestra BioMed Holdings, Inc. has a market capitalization of $234.13M, 59.88M shares outstanding, 66 institutional holders tracked. Key dilution vectors include approximately 17 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
66
💰 Cash Runway
40
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
5%
📉 Score Deterioration 10%
• Score in HIGH risk zone (61/100)
🔔 Track OBIO — Get forecast alerts →

💹 Market Data

Market Cap$234.13M
Shares Outstanding59.88M
Float33.55M
Cash$94.40M
Debt$15.00M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 39.7% shares (2026Q1 vs prior)
66 institutional holders · 30.76M shares
#1 PERCEPTIVE ADVISORS LLC 10.08M shares
#2 RTW INVESTMENTS, LP 8.31M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 4.41M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.22M
Days to Cover2.7
% of Float6.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for OBIO Shareholders

Orchestra BioMed Holdings, Inc. (OBIO) has a DilutionScore of 61/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: OBIO has approximately 17 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for OBIO in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for OBIO alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track OBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OBIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for OBIO
📊 OBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 OBIO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.